CONTENTS
Contents 2
Welcome
4 - 5
Is what you don’t know costing you? Why instrument utilization data could be your lab’s biggest asset
6 - 7
How can custom automation accelerate commercialization of biotechnology breakthroughs?
14 - 15 imely automation for ultra-sensitive T immunodiagnostics
8 - 9
NuGEN joins the Tecan family
10 - 11 Bacterial behavior offers insights into drug development
12 - 13
A revolution in milk sample analysis
14 - 15
Timely automation for ultra-sensitive immunodiagnostics
16 - 17 Post-mortem RNA sequencing revolutionizes neurological research
18 - 19
Exceptional analytical possibilities from a new cell culture environment
26 - 27 Automating genetic screening to support expansion
20 - 21 Finding a clinical future for HMGB1? 22 - 23
Correct identification of autoimmune diseases
24 - 25 Combining smart technology with clinical expertise
26 - 27 Automating genetic screening to support expansion
28 - 29 Automating protein purification 30 - 31
Designer chemotherapy
Applications and platforms presented in the Tecan Journal may not be available in all markets. Please consult your local Tecan office for information.
TECAN JOURNAL 1/2019
3